Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Thyroid Gland

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...

Goiter

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Synthesis and Regulation of Thyroid Hormones

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Disparities in utilization of high-volume thyroid surgeons for Graves disease: a statewide analysis.

Journal of the Endocrine Society·2026

Same author

Patient-Reported Outcome Measures Used in Primary Hyperparathyroidism: A Scoping Review.

Annals of surgical oncology·2026

Same author

Reoperative Parathyroidectomy: Recognizing Unique Risk Profiles.

The Journal of surgical research·2025

Same author

Factors Associated with Receiving Thyroid Cancer Care From High-Volume Surgeons: Analysis of a State-Wide Claims Registry.

Journal of the American College of Surgeons·2025

Same author

Bones, Stones, Groans, Moans, and a Path Forward With PROMs.

JAMA surgery·2025

Same author

The Evolving Role of Radioactive Iodine in Thyroid Cancer Diagnosis and Treatment.

Endocrinology and metabolism clinics of North America·2025

Search research articles

Related Experiment Video

Updated: Jul 20, 2026

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

The so-called stunning of thyroid tissue.

James C Sisson¹, Anca M Avram, Susan A Lawson

¹Department of Radiology, Division of Nuclear Medicine, University of Michigan Health System, Ann Arbor, 48109-0028, USA. jsisson@umich.edu

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine

|September 7, 2006

Summary

Thyroid stunning, a reduction in therapeutic radioactive iodine (131I) uptake after diagnostic doses, is caused by early destructive effects of the therapeutic dose, not impaired initial uptake.

More Related Videos

An Ex vivo Culture System to Study Thyroid Development

An Ex vivo Culture System to Study Thyroid Development

Published on: June 6, 2014

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Related Experiment Videos

Last Updated: Jul 20, 2026

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

An Ex vivo Culture System to Study Thyroid Development

An Ex vivo Culture System to Study Thyroid Development

Published on: June 6, 2014

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Area of Science:

Nuclear Medicine
Oncology
Endocrinology

Background:

Thyroid stunning describes reduced therapeutic radioactive iodine (131I) uptake following diagnostic 131I administration.
The underlying mechanism of stunning, specifically whether it affects initial uptake, remains unclear.

Purpose of the Study:

To investigate the hypothesis that thyroid stunning results from early destructive effects of therapeutic 131I doses.
To determine if the diagnostic dose impairs the initial uptake of 131I.

Main Methods:

Two studies quantified 131I concentrations in thyroid tissues of papillary thyroid carcinoma patients.
Radioactivity ratios (therapeutic/diagnostic, Rx/Dx) were measured at 2 days and extrapolated to 0-1 day to assess uptake and disappearance patterns.
Dose-response effects of diagnostic 131I and varying therapeutic doses were analyzed.

Main Results:

Most patients (74%) showed a 2-day Rx/Dx ratio <0.6, indicating reduced therapeutic uptake.
In patients with stunning (Rx/Dx <0.6 at 2 days), initial uptake (0-1 day) was similar for diagnostic and therapeutic doses in 5 out of 6 cases.
No correlation was found between diagnostic dose and the Rx/Dx ratio.

Conclusions:

Thyroid stunning is primarily caused by early destructive effects of therapeutic 131I, not by impaired initial uptake.
The diagnostic dose does not appear to hinder the initial 131I uptake in thyroid tissues.
These findings support the early destructive effect hypothesis for thyroid stunning, particularly at higher therapeutic doses.